GOLD COSMETICS ADI CLEAR- hydroquinone cream cream

Gold Cosmetics Adi Clear by

Drug Labeling and Warnings

Gold Cosmetics Adi Clear by is a Otc medication manufactured, distributed, or labeled by Peer Pharm Ltd. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

Hydroquinone 5%

PURPOSE

Face cream for gradual fading of dark spots

INDICATIONS & USAGE

Face cream for gradual fading of dark spots

Apply a very thin layer once a day, only at night, all over the face

DOSAGE & ADMINISTRATION

Apply a very thin layer once a day, only at night, all over the face​

WARNINGS

Warnings:
Sun exposure should be limit by using a sunscreen agent, a sun blocking agent, or protective clothing to cover bleached skin
when using and after using this product in order to prevent darkening from reoccurring.
Proper use of skin bleaching creams is extremely important, and directions should be followed carefully at all times.
Large skin areas, such as the entire face, should not be bleached at once due to the possibility of skin discoloration.
Product should be used on the darkened area of skin only.
For external use only.
Avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water.
Stop use and ask a doctor if condition worsens or does not improve after regular use as directed.
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.
If pregnant or breast feeding, ask a health professional before use.

KEEP OUT OF REACH OF CHILDREN

Keep out of reach of children

INACTIVE INGREDIENT

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

GOLD COSMETICS ADI CLEAR 
hydroquinone cream cream

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 69435-1904
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
HYDROQUINONE (UNII: XV74C1N1AE) (HYDROQUINONE - UNII:XV74C1N1AE)	HYDROQUINONE	5 mg  in 100 mL

Inactive Ingredients
Ingredient Name	Strength
GLYCERIN (UNII: PDC6A3C0OX)
JOJOBA OIL (UNII: 724GKU717M)
DECYL OLEATE (UNII: ZGR06DO97T)
SODIUM DITHIONATE (UNII: RPF7Z41GAW)
XANTHAN GUM (UNII: TTV12P4NEE)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
ALOE VERA LEAF (UNII: ZY81Z83H0X)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
WATER (UNII: 059QF0KO0R)
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)
STEARYL ALCOHOL (UNII: 2KR89I4H1Y)
CETEARETH-30 (UNII: 1R9DCZ5FOX)
STEARETH-21 (UNII: 53J3F32P58)
STEARETH-2 (UNII: V56DFE46J5)
EDETATE DISODIUM ANHYDROUS (UNII: 8NLQ36F6MM)
CHLORPHENESIN (UNII: I670DAL4SZ)
CETYL ALCOHOL (UNII: 936JST6JCN)
ALLANTOIN (UNII: 344S277G0Z)
ALPHA-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 69435-1904-1	30 mL in 1 TUBE; Type 0: Not a Combination Product	09/06/2019

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph not final	part358A	09/06/2019

Labeler - Peer Pharm Ltd (514678390)

Registrant - Peer Pharm Ltd (514678390)

Establishment
Name	Address	ID/FEI	Business Operations
Peer Pharm Ltd		514678390	manufacture(69435-1904) , label(69435-1904)